Catalyst Pharmaceutical Partners (CPRX)
NASDAQ:CPRX
Want to see CPRX full AI Analyst Report?
Catalyst Pharma (CPRX) Ownership Overview
5.52% Insiders
18.77% Mutual Funds
16.84% Other Institutional Investors
28.28% ETFs
30.60% Public Companies and Individual Investors
The ownership structure of Catalyst Pharma (CPRX) stock is a mix of institutional, retail, and individual investors. Approximately 63.89% of the company’s stock is owned by Institutional Investors, 5.52% is owned by Insiders, and 30.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 16, 2025 | xxxxxxxxxxxxx | $621778 | |
Nov 28, 2025 | xxxxxxxxxxxxx | $256233 | |
Sep 05, 2025 | xxxxxxxxxxxxx | $987200 | |
Jun 12, 2025 | xxxxxxxxxxxxx | $103649 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $2079840 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $51746073 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $97643536 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $2034504 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,983,960 | Institution | 10.61% | 406,268,108 | |
| 6,610,017 | Institution | 5.40% | 206,827,432 | |
| 4,999,363 | Institution | 4.09% | 156,430,068 | |
| 4,848,045 | Institution | 3.96% | 151,695,328 | |
| 4,477,888 | Institution | 3.66% | 140,113,116 | |
| 4,171,559 | Insider | 3.41% | 130,528,081 | |
| 3,943,600 | Institution | 3.22% | 123,395,244 | |
| 2,089,906 | Institution | 1.71% | 65,393,159 | |
| 1,385,845 | Institution | 1.13% | 43,363,090 | |
| 1,311,486 | Institution | 1.07% | 41,036,397 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,999,363 | Institution | 4.09% | 156,430,068 | |
| 1,385,845 | Institution | 1.13% | 43,363,090 | |
| 1,311,486 | Institution | 1.07% | 41,036,397 | |
| 1,221,382 | Institution | 1.00% | 38,217,043 | |
| 1,157,986 | Institution | 0.95% | 36,233,382 | |
| 1,030,659 | Institution | 0.84% | 32,249,320 | |
| 746,249 | Institution | 0.61% | 23,350,131 | |
| 742,200 | Institution | 0.61% | 23,223,438 | |
| 689,130 | Institution | 0.56% | 21,562,878 | |
| 652,111 | Institution | 0.53% | 20,404,553 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,993,913 | Institution | 5.71% | 218,839,538 | |
| 4,304,450 | Institution | 3.52% | 134,686,241 | |
| 3,725,949 | Institution | 3.04% | 104,810,945 | |
| 2,709,341 | Institution | 2.21% | 84,775,280 | |
| 2,551,772 | Institution | 2.09% | 79,819,428 | |
| 1,304,033 | Institution | 1.07% | 36,682,448 | |
| 1,056,100 | Institution | 0.86% | 33,034,808 | |
| 1,028,333 | Institution | 0.84% | 32,176,540 | |
| 949,601 | Institution | 0.78% | 29,713,015 | |
| 645,594 | Institution | 0.53% | 20,200,636 |
FAQ
Who Owns Catalyst Pharmaceutical Partners (CPRX)?
According to the latest TipRanks data, approximately 16.84% of the company's stock is held by institutional investors, 5.52% is held by insiders, and 30.60% is held by retail investors.
What percentage of Catalyst Pharmaceutical Partners (CPRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.84% of Catalyst Pharmaceutical Partners (CPRX) stock is held by institutional investors.
What percentage of Catalyst Pharmaceutical Partners (CPRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.60% of Catalyst Pharmaceutical Partners (CPRX) stock is held by retail investors.
Who owns the most shares of Catalyst Pharmaceutical Partners (CPRX)?
iShares owns the most shares of Catalyst Pharmaceutical Partners (CPRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.